Table 3.
Multivariate analysis according to early neurological deterioration.
| Unadjusted OR (95% CI) | P value | Model 1 |
P value | Model 2 |
P value | |
|---|---|---|---|---|---|---|
| Adjusted OR (95% CI) | Adjusted OR (95% CI) | |||||
| Cystatin C | 0.026 | 0.026 | 0.037 | |||
| Q1 | 1 (Reference) | 1 (Reference) | 1 (Reference) | |||
| Q2 | 1.33 (0.63–2.82) | 0.457 | 1.59 (0.70–3.58) | 0.267 | 1.33 (0.61–2.90) | 0.474 |
| Q3 | 2.14 (1.07–4.31) | 0.032 | 2.75 (1.25–6.04) | 0.012 | 2.34 (1.11–4.93) | 0.025 |
| Q4 | 2.53 (1.28–5.03) | 0.008 | 3.12 (1.36–7.16) | 0.007 | 2.76 (1.25–6.11) | 0.012 |
| Age | 1.06 (1.03–1.09) | <0.001 | 1.04 (1.00–1.08) | 0.037 | 1.04 (1.00–1.08) | 0.031 |
| Infection | 2.31 (1.17–4.56) | 0.016 | 1.63 (0.74–3.59) | 0.230 | 1.61 (0.73–3.56) | 0.240 |
| WBC (10/µL) | 6.65 (1.27–34.89) | 0.025 | 4.90 (0.83–28.98) | 0.080 | 4.26 (0.74–24.61) | 0.106 |
| FBS | 1.01 (1.00–1.01) | 0.022 | 1.01 (1.00–1.01) | 0.068 | 1.01 (1.00–1.01) | 0.033 |
CHD: coronary heart disease; GFR: glomerular filtration rate; WBC: white blood cell; FBS: fasting blood sugar.
Model 1: Adjusting for cystatin C, age, sex, hypertension, smoking, CHD, previous stroke/TIA, lesion location, GFR, FBS, WBC, haemoglobin, HDL, TG, infections, significant stenosis. Model 2: Adjusting for cystatin C, age, sex, hypertension, smoking, CHD, previous stroke/TIA, lesion location, FBS, WBC, haemoglobin, HDL, TG, infection, significant stenosis.